Masimo Corp. (NASDAQ: MASI) reported Q2 EPS of $0.43, $0.11 better than the analyst estimate of $0.32. Revenue for the quarter came in at $155.7 million versus the consensus estimate of $149.94 million.

Masimo Corp. sees FY2015 EPS of $1.61, versus the consensus of $1.36. Masimo Corp. sees FY2015 revenue of $621 million, versus prior guidance of $608 million and the consensus of $613.02 million.

Joe Kiani, Chairman and Chief Executive Officer of Masimo, said, “Our second quarter results reflect the continued demand for our SET® Pulse Oximetry technology and our emerging rainbow® SET® Pulse CO-Oximetry technology. The years of building a solid foundation of technologies and products that save and improve lives, along with a build out of our infrastructure to best serve our customers, should allow us to continue to deliver positive returns for our shareholders.”

For earnings history and earnings-related data on Masimo Corp. (MASI) click here.